Cheya Pope's Email Addresses & Phone Numbers

Vice President, Corporate Affairs & Patient Advocacy @ Epizyme Lead Epizyme's corporate communications and media engagement, patient advocacy, product communications, internal communications, and corporate social responsibility efforts. Greater Boston AreaExecutive Director, Global Corporate Affairs @ Intercept Pharmaceuticals • Led Intercept's global corporate communications, brand PR and patient advocacy strategies and initiatives, including product communications, patient engagement initiatives,...

Vice President, Corporate Affairs & Patient Advocacy @ Epizyme Lead Epizyme's corporate communications and media engagement, patient advocacy, product communications, internal communications, and corporate social responsibility efforts. Greater Boston AreaExecutive Director, Global Corporate Affairs @ Intercept Pharmaceuticals • Led Intercept's global corporate communications, brand PR and patient advocacy strategies and initiatives, including product communications, patient engagement initiatives, disease education, media relations, and advocacy partnerships to raise the profile of Primary Biliary Cholangitis (PBC), a rare liver disease• Liaised with the PBC, liver, and women's health communities, presented at patient conferences, organized patient advisory boards and focus groups, facilitated clinical updates to the patient community, and provided key insights to colleagues to shape the company’s patient engagement efforts• Built support for Intercept's product portfolio via media relations and data communications; led communications strategy related to all regulatory milestones, pricing and HTA issues; developed communications initiatives to support clinical trials education and recruitment• Led Intercept's corporate communications and branding efforts, including responsibility for the corporate website, company values, corporate collateral, corporate media, community relations, and charitable grants• Developed new online resources, tools, symptom trackers, and dialogue guides to educate and empower the PBC patient community; cultivated patient speakers to humanize PBC for employee communications, as well as patient advocacy and public relations programs• Led Intercept's internal communications to foster employee engagement and build our desired corporate culture• Collaborated with colleagues in Marketing, Regulatory, Market Access, Market Research, and Medical Affairs to ensure the patient perspective is incorporated in Intercept’s work on research, regulatory, reimbursement, and educational initiatives• Prepared for upcoming regulatory milestones, including comprehensive plans to ensure the patient voice is heard by key decision makers and payers• Managed three agencies and an internal team• Promoted to Executive Director in December 2015 From January 2014 to April 2017 (3 years 4 months) Boston / NYCSenior Director of Global Patient Advocacy @ sanofi-aventis • Led the division’s outreach to global non-profit cancer organizations and patient advocates, to initiate new partnerships, increase awareness of Sanofi’s oncology therapies and pipeline, engage the community in advancing public health concerns impacting cancer patients, and to provide counsel to internal stakeholders on the unique patient challenges and issues in various countries and regions• Provided strategic oversight to Sanofi affiliates on patient advocacy issues to ensure alignment with the division’s business priorities• Partnered with the oncology brand teams to drive patient engagement initiatives throughout the drug development continuum, from R&D through to launch and commercialization• Coordinated and led patient advocate advisory boards, bringing together global advocate leaders to provide insights on pressing patient issues and needs; ad boards were hosted with leaders from the colon cancer, prostate cancer and myelofibrosis communities• Spearheaded new initiatives to develop innovative patient solutions and support programs in developing countries – including Brazil, India, Mexico, and the Middle East – as well as in the U.S. and Europe• Partnered with Corporate Communications to develop and lead the Oncology Division’s community relations outreach and CSR efforts; provided strategic sponsorships to local, regional and global patient organizations• Cultivated opportunities to infuse the patient perspective throughout the division, including facilitating patient speakers at employee events and sharing patient insights from social media forums with colleagues• Created program frameworks, resources and advocacy models that the affiliates can use to launch patient outreach initiatives in their own countries From August 2010 to January 2014 (3 years 6 months) Cambridge, MADirector of Advocacy @ Genomic Health, Inc. • Spearheaded the company’s outreach to 125+ U.S. and global cancer advocacy organizations, to stimulate awareness of the Oncotype DX Breast and Colon Cancer Assays, broaden understanding of personalized medicine, and build goodwill throughout the community• Developed and launched Genomic Health's flagship advocacy program, My Breast Cancer Coach, an innovative partnership with Breastcancer.org, to help newly diagnosed women navigate their online search for breast cancer information and provide them with personalized reports of relevant treatment choices to discuss with their physicians• Enlisted key advocacy organizations to send over 250 letters to 50+ payers, successfully urging them to increase patient access to genomic tests by covering the cost of Oncotype DX• Leveraged relationships with advocate thoughtleaders to build community support for the company’s position on high-level policy and access issues, such as federal regulation of diagnostics and payer policies• Recruited patients who used Oncotype DX to join the company’s corps of patient ambassadors, sharing their personal cancer stories with advocates to drive awareness of the critical role of Oncotype DX• Fostered ongoing opportunities for scientific education and direct dialogue between the company’s Medical Affairs group and advocates • Built upon Genomic Health's strong track record of advocacy in the United States, by developing and executing a global outreach strategy to engage advocates internationally, in alignment with the company's ex-U.S. target markets• Shared advocacy expertise internally to ensure the patient perspective was incorporated into marketing materials and PR campaigns• Promoted from Associate Director to Director in 2008 From January 2007 to August 2010 (3 years 8 months) Advocacy Relations Consultant @ Self-employed • Supported biomedical, healthcare, and non-profit patient advocacy clients in developing and enhancing community partnerships; provided strategic counsel on partnership opportunities, as well as insight into successfully navigating community politics• Developed strategic plans, patient education programs, community outreach materials, presentations, and relevant metrics, to advance clients’ advocacy initiatives while demonstrating measurable success to internal stakeholders From 2005 to 2007 (2 years) Senior Manager, Advocacy Relations @ Genentech, Inc. • Directed Genentech’s outreach to the cancer advocate community, building support for the company’s oncology franchise and rich pipeline, and launching Avastin and Tarceva• Partnered with non-profit leaders to successfully navigate difficult issues such as expanded access to investigational therapies, continuously enhancing and protecting Genentech’s corporate image among the patient community, and preventing negative media• Engaged advocate leaders to influence critical components of the FDA's review process for Avastin, reducing time to FDA approval by one month and increasing 2004 sales • Frequently mobilized an array of internal and external stakeholders to facilitate decision-making and build consensus on complex issues• Developed and oversaw key outreach strategies, including ongoing advocate communications, patient education programs, and company-sponsored community events• Developed strategic grant-giving criteria to create alignment with Genentech’s business goals• Promoted from Manager to Senior Manager in 2004 From 2002 to 2005 (3 years)